This article discusses Jim Cramer's bold predictions about healthcare stocks, focusing on UnitedHealth Group Incorporated (UNH) amidst President-elect Trump's plans to tackle healthcare costs. Cramer emphasizes the impact on healthcare benefit managers and pharmaceutical chains due to the middlemen's role in the industry.